In this article, we will list the 5 Best Consumer Staples Penny Stocks to Buy Now. Please visit 10 Best Consumer Staples Penny Stocks to Buy Now if you’d like to see an extended list and methodology behind it.

5. Coty Inc. (NYSE:COTY)

Coty Inc. (NYSE:COTY) is one of the 10 best consumer staples penny stocks to buy now.

On April 14, Barclays reduced the price target on Coty Inc. (NYSE:COTY) from $2.50 to $2 while reaffirming an Underweight rating on the stock. This downward price target revision is driven by a general realignment across the consumer staples group as part of a first-quarter preview.

Heading into the upcoming earnings prints, the firm is adopting a much more cautious stance across the board, largely due to mounting pressure from higher input costs. Furthermore, for certain key companies in the food sector, Barclays has warned of growing concerns about the long-term sustainability of dividends.

On March 30, Steve Powers from Deutsche Bank reduced the price target on Coty Inc. (NYSE:COTY) from $3 to $2 while maintaining a Hold rating on the stock. The analyst observes a valid and widespread push coming within the consumer packaged goods (CPG) sector because of the Middle East conflict. In March, the companies underperformed due to issues such as cost inflation, demand destruction through trade-down, and negative currency effects.

Despite the bearish views noted above, the stock carries a median 1-year price target of $3.41, according to the consensus as of the April 17 close. This results in an upside potential of more than 43%, making Coty Inc. (NYSE:COTY) an attractive investment option across the consumer staples penny stocks universe.

Coty Inc. (NYSE:COTY) is a producer, distributor, and marketer of beauty products around the world. It operates through various retail and online channels, and offers different products, including color cosmetics, fragrances, skin care products, and more. It covers a long list of brands such as Gucci, Orveda, Vera Wang, Tiffany & Co., and more.

4. Village Farms International Inc. (NASDAQ:VFF)

Village Farms International Inc. (NASDAQ:VFF) is one of the 10 best consumer staples penny stocks to buy now.

On March 30, Village Farms International Inc. (NASDAQ:VFF) reported that the long-serving Chief Financial Officer, Stephen Ruffini, will be retiring from his post following the completion of the company’s succession plan. The company has ensured that the departure of Mr. Ruffini would not pose any problem with respect to accounting, financial reporting, management, and policy matters.

While Village Farms has already begun recruiting to replace Mr. Ruffini, the succession plan would see him in a new executive role focused on mergers and acquisitions. This is consistent with Village Farms’ corporate strategy to scale up, both organically and through accretive acquisitions around the globe.

Back on March 31, Village Farms International Inc. (NASDAQ:VFF) finalized improved terms on its long-standing $15.4 million loan agreement with Farm Credit Canada. This financial update is supported by the drop in interest rate by 50 basis points, combined with maturity extension to February 2031. All other basic requirements remain the same; however, the debt now has a variable rate that has dropped below 7.0%.

To effectively enhance corporate liquidity to support ongoing cannabis, plant-based, and sustainable energy efforts across Canada, Europe, and the United States, management has portrayed this amendment as a significant vote of confidence from lenders. Nonetheless, the broader street remains slightly cautious.

Village Farms International Inc. (NASDAQ:VFF) is engaged in the production and supply of cannabis goods to authorized vendors and provincial governments around the world. The company also offers wellness and cannabinoid-based health products, including edibles and ingestibles. It is also a supplier of cannabis products for certain authorized coffee shops.

3. Yatsen Holding Ltd. (NYSE:YSG)

Yatsen Holding Ltd. (NYSE:YSG) is one of the 10 best consumer staples penny stocks to buy now.

As of the April 17 closing, the stock offers more than 76% potential upside. This is based on a $5.80 median 1-year price target. Such upside creates a strong appeal for Yatsen Holding Ltd. (NYSE:YSG) as one of the best penny stocks in the consumer staples category.

What also supports the bullish stance around Yatsen Holding Ltd. (NYSE:YSG), is its strategic partnerships and capital raising efforts to fuel growth opportunities. During mid-March, the company announced a definitive agreement with an investment vehicle affiliated with Trustar Capital and founder Jinfeng Huang to subscribe for approximately $120 million in convertible senior notes.

These will be issued in two equal tranches, along with warrants to purchase Class A ordinary shares. Even though Trustar Capital is a participant in this transaction, Mr. Huang will be making the investment, which shows how much faith he has in the future of the company. Note that the first note will be released in March 2026, whereas the second one will appear in the market during the rest of that year.

The money raised from the issue will be used for research and development, logistics on a global scale, expansion internationally, and acquisition purposes. As Mr. Huang stated in relation to this transaction, it proves his confidence in Yatsen’s strategic approach going forward. The deal indicates an expanding strategic relationship where Trustar Capital uses its wide network to help Yatsen realize the synergies by making cross-border acquisitions within the value chain of the beauty industry.

Yatsen Holding Ltd. (NYSE:YSG) is involved in the production and sale of beauty products in China. Its product portfolio consists of colored products for the eyes, face, and lips. The company also offers skin care products like creams, serums, masks, toners, and more. It also sells beauty devices, tools, and kits through both online and offline channels.

2. Niagen Bioscience Inc. (NASDAQ:NAGE)

Niagen Bioscience Inc. (NASDAQ:NAGE) is one of the 10 best consumer staples penny stocks to buy now.

On April 9, Niagen Bioscience Inc. (NASDAQ:NAGE) announced that Nicotinamide Riboside Chloride, the patented form of nicotinamide riboside used in its key product, Niagen, was granted an official dietary supplement ingredient monograph by the United States Pharmacopeia.

Following the announcement, the CEO, Rob Fried, pointed out that it was an important milestone for the entire NAD+ supplement sector. As he explained, NR had become the only substance within this group to be provided with a published standard by the Pharmacopeia, while NMN and NAD+ lacked such standards. Such developments around Niagen have led to a favorable sentiment for the stock, which is one of the most promising consumer staples names.

Back on March 10, the company shared that it had obtained US Patent No. 12,558,367 Niagen. This intellectual property expansion was backed by the company’s vigorous efforts to create a vast competitive moat around commercial longevity science. As the natural cellular energy levels gradually decrease with aging, the wellness sector as a whole is quickly shifting from simple oral supplements to extremely effective therapeutic delivery systems.

Rob Fried, the CEO, stated unequivocally that this particular patent ensures crucial intellectual protection through 2044. This demonstrates the company’s uniqueness in providing a much better aqueous-based solution under the new Niagen Plus brand. In fact, it fully avoids the physical discomfort typically associated with these particular IV medicines while circumventing normal digestion to enable far faster infusion times.

Niagen Bioscience Inc. (NASDAQ:NAGE) is involved in the development and commercialization of aging products. It sells the dietary supplement nicotinamide adenine dinucleotide (NAD+), pharmaceutical- and food-grade Niagen, and the NAD+ precursor nicotinamide riboside. It sells products through multiple channels like e-commerce, specialty retailers, and licensed healthcare resellers.

1. BRC Inc. (NYSE:BRCC)

BRC Inc. (NYSE:BRCC) is one of the 10 best consumer staples penny stocks to buy now.

As of the April 17 close, BRC Inc. (NYSE:BRCC) had a moderately bullish consensus sentiment. The stock received Buy ratings from both analysts who cover it. With a median 1-year price target of $2.50, it offers a highly lucrative upside potential of more than 183% at the prevailing level. This makes it one of the most attractive penny stocks within the consumer staples category.

What also makes the story more compelling is the company’s proactive approach towards securing future financing. On March 26, it filed for a mixed securities shelf worth $500 million, which is aimed at supporting future expansion plans.

In early March, the company shared its forecasts for 2026, with an expectation of at least 7% expansion of topline. This will amount to $425 million in revenue and reflects strong trends across the packaged coffee segment. The management expects gross margins to stay within 34% to 36% range, which is marginally lower than the prior-year figures.

EBITDA is projected to grow 30% from $21.4 million in 2025. Such an optimistic outlook should entice investors who are looking for opportunities within the consumer staples penny stock universe.

BRC Inc. (NYSE:BRCC) is a buyer, roaster, and seller of coffee beans and accessories across the United States. Its product portfolio includes coffee brewing equipment, apparel, outdoor and lifestyle gear, and Black Rifle-branded apparel. It mainly sells through the wholesale, e-commerce, and outpost channels, as well as directly to consumers.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 12 Oversold Financial Stocks to Invest in According to Hedge Funds.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.